BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

AlTi Global, Inc. is a financial services company, which engages in the provision of investment, advisory, and administrative services. The company was founded on December 18, 2020 and is headquartered in New York, NY.

Superior Industries International, Inc. engages in the design and manufacture of aluminum road wheels for passenger cars and light-duty vehicles. It operates through the North America and Europe segments. The company was founded by Louis L. Borick in 1957 and is headquartered in Southfield, MI.

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.

Incannex Healthcare, Inc. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It operates through the following segments: Psychedelic Products, Cannabinoid Products, and Corporate. The Psychedelic Products segment is involved in the use of psychedelic medicine and therapies for the treatment of mental health disorders. The Cannabinoid Products segment focuses on the use of medicinal cannabinoid products. The Corporate segment includes management of the organization, capital management, and management of resources. The company was founded on April 27, 2001 and is headquartered in New York, NY.

Lanvin Group Holdings Ltd. engages in the manufacturing and provision of leather goods, footwear, and accessories. The firm operates through the five portfolio brands: Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. The company was founded in 1889 and is headquartered in Shanghai, China.

SYLA Technologies Co., Ltd. engages in the operation of property investment platform. Its asset management platform includes Rimawari-kun and Rimawari-kun Pro. Rimawari-kun targets individual, in which this platform to facilitate real estate crowdfunding as well as the purchase and sale of real estate, sale of solar power plants which it constructs, and sale of computers. Rimawari-kun Pro targets corporate investors, institutional investors, and high-net-worth individuals. It exhibits properties on this platform as well as wide range of properties from other companies. Its business also includes asset management, including leasing, brokerage, and management of real estate, and operation and maintenance of solar power plants. The company was founded on March 3, 2009 and is headquartered in Tokyo, Japan.

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.

Shutterstock, Inc. engages in the provision of a global creative platform. The company offers data, distribution, and services. Its contents include images, footage, music, three dimensional (3D) models, and generative artificial intelligence. The company was founded by Jonathan Evan Oringer in 2003 and is headquartered in New York, NY.

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.